Emsam (selegiline) will be the first PATCH for depression

Emsam (selegiline) will be the first PATCH for depression.

It will be used as an alternative to oral MAO inhibitors... in patients who don't respond to other antidepressants.

Oral selegiline is selective for MAO-B at the low dose used for Parkinson's...but it's nonselective at higher doses needed for depression.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote